Search results for "Urinary incontinence"

showing 10 items of 128 documents

Ureterosigmoidostomy: an outdated approach to bladder exstrophy?

1990

Long-term results among 46 children with ureterosigmoidostomy are presented. The indication for ureterosigmoidostomy had been bladder exstrophy in 40 patients, incontinent epispadias in 5 and neurogenic bladder dysfunction in 1. Of the 40 patients with bladder exstrophy 8 had undergone ureterosigmoidostomy after failure of other types of urinary tract reconstruction (6 had upper tract dilatation before ureterosigmoidostomy). Three patients with previously damaged upper urinary tracts required early postoperative conversion because of severely increasing kidney dilatation. Three other patients required conversion after a mean of 10 years to preserve kidney function. One patient died after 16…

Malemedicine.medical_specialtyAdolescentUrologyUrinary systemmedicine.medical_treatmentUrologyRenal functionUrinary DiversionUreterostomyUreterosigmoidostomyPostoperative ComplicationsTubular adenomaColon SigmoidmedicineHumansChildNeurogenic bladder dysfunctionUrinary bladderbusiness.industryBladder ExstrophyInfantUrographymedicine.diseaseSurgeryBladder exstrophymedicine.anatomical_structureUrinary IncontinenceChild PreschoolColonic NeoplasmsFemalebusinessFollow-Up StudiesThe Journal of urology
researchProduct

Evaluation of antidiuretic hormone before and after long-term treatment with desmopressin in a group of enuretic children

1998

Objective To determine the effect of long-term desmopressin therapy in enuretic patients on the levels of antidiuretic hormone (ADH) during and after the end of therapy. Patients and methods The study comprised 25 outpatients (18 boys and seven girls) aged 8–12 years at the start of therapy and 12–16 years at the end. The morning (08.00 hours) plasma ADH level was determined before treatment (T0) with desmopressin and 2 years after (T1) ending the therapy. Seven of the 25 patients evaluated had monosymptomatic (simple enuresis, SE) and 18 had other symptoms (complex enuresis, CE). Results In the patients with SE, the mean (SD) duration of therapy was 305 (183) days and they were re-evaluate…

Malemedicine.medical_specialtyAdolescentVasopressinsUrologyUrinary incontinenceRenal AgentsGastroenterologyCholinergic AntagonistsEnuresisInternal medicineHumansMedicineDeamino Arginine VasopressinChildOxybutyninDesmopressinMorningbusiness.industryEnuresisLong-Term CareEndocrinologyEl NiñoMandelic AcidsDrug Therapy CombinationFemalemedicine.symptombusinesshormones hormone substitutes and hormone antagonistsHormoneAntidiureticmedicine.drugBJU International
researchProduct

Enuresis Subtypes Based on Nocturnal Hypercalciuria: A Multicenter Study

2003

Purpose: Desmopressin may not be effective for nocturnal enuresis associated with polyuria and hypercalciuria. Nighttime hypercalciuria in an enuretic population from 5 centers and its correlation with nighttime polyuria were verified. Materials and Methods: A total of 450 enuretic patients (278 males, 172 females, mean age 9.7 years) were evaluated with 72-hour micturition charts, urinalysis, serum creatinine and osmolarity, diurnal and nocturnal electrolytes with fractional Na+ and K+ urinary excretion, and nocturnal (4 a.m.) plasma vasopressin. Creatinine electrolytes and osmolarity were measured in daytime (8 a.m. to 8 p.m.) and nighttime (8 p.m. to 8 a.m.) urine volumes. Patients were …

Malemedicine.medical_specialtyAdolescentendocrine system diseasesUrinalysisVasopressinsUrologymedia_common.quotation_subjectPopulationUrinary incontinenceUrologyUrinary incontinenceurologic and male genital diseasesUrinationDiagnosis DifferentialElectrolytesAdrenocorticotropic HormonePolyuriaEnuresisElectrolyteInternal medicineEnuresimedicineHumansEnuresis; Polyuria; Urinary incontinence; Vasopressin; Adolescent; Adrenocorticotropic Hormone; Calcium; Child; Circadian Rhythm; Creatinine; Deamino Arginine Vasopressin; Diagnosis Differential; Electrolytes; Enuresis; Female; Humans; Male; Polyuria; Vasopressins; UrologyDeamino Arginine VasopressinHypercalciuriaChildDesmopressineducationmedia_commoneducation.field_of_studymedicine.diagnostic_testPolyuriabusiness.industryEnuresismedicine.diseasefemale genital diseases and pregnancy complicationsCircadian RhythmEndocrinologyCreatinineCalciumFemalemedicine.symptombusinessVasopressinhormones hormone substitutes and hormone antagonistsHumanmedicine.drugJournal of Urology
researchProduct

Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate

2021

Background: Although an increasing number of prostate cancer (PCa) patients received holmium laser enucleation of the prostate (HoLEP) previously for benign prostatic obstruction (BPO), there is still no evidence regarding the outcomes of radical prostatectomy (RP) in this setting. Objective: To assess functional and oncological results of RP in PCa patients who received HoLEP for BPO previously in a contemporary multi-institutional cohort. Design, setting, and participants: A total of 95 patients who underwent RP between 2011 and 2019 and had a history of HoLEP were identified in two institutions. Functional as well as oncological follow-up was prospectively assessed and retrospectively an…

Malemedicine.medical_specialtyHolmium laser enucleation of the prostate; Localized prostate cancer; Patient-reported outcomes; Radical prostatectomy; Urinary continenceUrologymedicine.medical_treatmentEnucleation030232 urology & nephrologyUrologyProstatic HyperplasiaUrinary incontinenceLasers Solid-State03 medical and health sciencesBladder outlet obstructionProstate cancerHolmium0302 clinical medicineErectile DysfunctionmedicineHumansRetrospective StudiesProstatectomyLocalized prostate cancerPatient-reported outcomesProstatectomybusiness.industryHazard ratioProstateUrinary continenceOdds ratiomedicine.diseaseRadical prostatectomyHolmium laser enucleation of the prostate030220 oncology & carcinogenesisPropensity score matchingmedicine.symptombusiness
researchProduct

Long-Term Efficacy of Shunt Therapy in Idiopathic Normal Pressure Hydrocephalus.

2019

Background: Idiopathic normal pressure hydrocephalus (iNPH) is one of the very few treatable types of dementia. Shunt therapy has been shown to be effective in improving symptoms. However, the long-term results of cerebrospinal fluid diversion are variable. The aim of this retrospective study was to investigate long-term outcomes of patients with idiopathic normal pressure hydrocephalus treated with ventriculoperitoneal shunt by using programmable valves. Methods: Symptoms before treatment were recorded. Clinical symptoms and outcome after ventriculoperitoneal shunt were assessed based on changes in gait, urinary incontinence, and cognitive dysfunction at yearly follow-up spanning at least …

Malemedicine.medical_specialtyIdiopathic normal pressure hydrocephaluUrinary incontinenceShuntVentriculoperitoneal Shunt03 medical and health sciences0302 clinical medicineCerebrospinal fluid diversionmedicineDementiaHumansCognitive DysfunctionSurgical treatmentOutcomeAgedAged 80 and overbusiness.industryShunt malfunctionRetrospective cohort studyMiddle Agedmedicine.diseaseHydrocephalus Normal PressureShunt (medical)SurgeryTreatment Outcome030220 oncology & carcinogenesis(Idiopathic) normal pressure hydrocephalusSurgeryFemaleNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgeryFollow-Up StudiesWorld neurosurgery
researchProduct

Incontinence and constipation in adolescent patients with anorexia nervosa : Results of a multicenter study from a German web-based registry for chil…

2019

OBJECTIVE: Nocturnal enuresis (NE), daytime urinary incontinence (DUI), and fecal incontinence (FI) are common disorders in childhood and are frequently accompanied by comorbid psychiatric disorders. Despite a high association between urinary and fecal incontinence with psychiatric and neurodevelopmental disorders, research on comorbidity between incontinence and anorexia nervosa (AN) remains scarce. Yet, it is well known that somatic consequences of AN include metabolic and gastrointestinal disorders. The study sought to assess the prevalence of incontinence and constipation in children and adolescents with AN and to examine associations of these two symptoms with body weight at admission …

Malemedicine.medical_specialtyPediatricsConstipationAdolescentPopulation150Medizin610Physical examinationanorexia nervosabody weightEnuresisGermanySurveys and QuestionnairesEpidemiologyMedicineFecal incontinenceHumansRegistrieseducationChildnocturnal enuresiseducation.field_of_studymedicine.diagnostic_testbusiness.industryconstipationmedicine.diseaseComorbidityPsychiatry and Mental healthAnorexia nervosa (differential diagnoses)daytime urinary incontinenceFemalemedicine.symptomDiurnal EnuresisbusinessFecal Incontinence
researchProduct

Neourethra: a new two-stage procedure for reconstruction of the functional urethra.

1983

Abstract In 14 male dogs, the functional urethra was replaced by a bladder flap tube in a 2-stage procedure. In the 1st stage of the operation a bipedicle strip from the anterior bladder wall was tubularized around a 10F or 12F catheter. After 10 to 12 weeks the 2nd stage of the procedure was performed: the bladder neck was transected and sutured, and the cranial pedicle of the bipedicle tube was transected and pulled through the bluntly dissected pelvic floor muscles. From the distal end of the tube a perineal urostoma was created to facilitate radiological and urodynamic followup. Eight dogs completed a followup 5 months after the 2nd procedure. Urodynamic and x-ray studies were done preo…

Malemedicine.medical_specialtyPelvic floorbusiness.industryUrologyUrinary BladderBladder flapAnatomySurgical FlapsSurgeryCatheterizationNeck of urinary bladderCatheterUrodynamicsUrethramedicine.anatomical_structureDogsUrinary IncontinenceUrethraPressureMedicineAnimalsStage (cooking)Tube (container)businessThe Journal of urology
researchProduct

Antibiotic Coating of the Artificial Urinary Sphincter (AMS 800): Is it Worthwhile?

2016

Objective To investigate the impact of the antibiotic coating InhibiZone on the infection and explantation rates of the AMS 800 in comparison to the AMS 800 without InhibiZone. Materials and Methods We retrospectively identified 305 patients with an AMS 800 in a multicenter cohort study. Patients were subsequently divided into InhibiZone and without InhibiZone-coated groups. Infection and explantation rates were analyzed by univariate and consecutively by multivariate logistic regression adjusted to variable risk factors. The infection-free interval was estimated by Kaplan-Meier plot and compared by the log-rank test. A P value below .05 was considered statistically significant. Results We …

Malemedicine.medical_specialtyProsthesis-Related InfectionsMultivariate analysismedicine.drug_classUrologyAntibiotics030232 urology & nephrologyLong Term Adverse EffectsProsthesis DesignLogistic regressionRisk AssessmentGastroenterologyCohort StudiesArtificial urinary sphincter03 medical and health sciences0302 clinical medicineCoated Materials BiocompatibleRisk FactorsInternal medicineOutcome Assessment Health CaremedicineHumansAgedUnivariate analysisbusiness.industrySignificant differenceMiddle AgedAnti-Bacterial AgentsSurgeryUrinary Incontinence030220 oncology & carcinogenesisUrinary Tract InfectionsCohortUrinary Sphincter ArtificialFemalebusinessCohort studyUrology
researchProduct

Does concomitant diabetes affect treatment responses in overactive bladder patients?

2013

Summary Aims To compare the efficacy and tolerability of a muscarinic receptor antagonist, darifenacin, in the treatment of overactive bladder (OAB) patients with concomitant diabetes as compared with those without comorbidities. Methods Post hoc exploratory analysis of a published, large, non-interventional study in OAB patients treated with darifenacin including 532 diabetics and 1315 controls. Associations of diabetes with treatment responses were evaluated by multiple regression models. Results Diabetics (largely type 2 patients) and controls differed in baseline age, body weight, duration of OAB symptoms and presence of comedications. However, they exhibited similar OAB symptom episode…

Malemedicine.medical_specialtyPyrrolidinesMuscarinic Antagonistsurologic and male genital diseasesAffect (psychology)Diabetes ComplicationsDiabetes mellitusInternal medicineMuscarinic acetylcholine receptorDarifenacinMedicineHumansBenzofuransDose-Response Relationship Drugbusiness.industryUrinary Bladder OveractiveAntagonistUrinary Bladder DiseasesGeneral MedicineMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsEndocrinologyTreatment OutcomeUrinary IncontinenceTolerabilityOveractive bladderConcomitantRegression AnalysisFemaleNocturiabusinessmedicine.drugInternational journal of clinical practice
researchProduct

Lower Urinary Tract Symptoms: What's New in Medical Treatment?

2018

Abstract Context Pharmacological treatment is a cornerstone in the management of patients with lower urinary tract symptoms (LUTS). Objective To review emerging evidence in the medical treatment of LUTS. Evidence acquisition An Embase/Pubmed-based literature search was conducted in December 2017, screening for randomized controlled trials (RCTs), prospective and retrospective series, animal model studies, and reviews on medical treatment of LUTS. Evidence synthesis The main medical innovation in recent years in overactive bladder (OAB) has been the approval of the first β 3 -adrenoceptor agonists (mirabegron) and intradetrusor onabotulinum toxin A, while several other drugs such as antiepil…

Malemedicine.medical_specialtyReceptors VasopressinUrologyUrinary Bladder030232 urology & nephrologyUrologyProstatic HyperplasiaUrinary incontinenceAdrenergic beta-3 Receptor Agonistsurologic and male genital diseases03 medical and health sciences0302 clinical medicineLower Urinary Tract SymptomsLower urinary tract symptomsmedicineDesmopressin AcetateNocturiaHumansDeamino Arginine VasopressinProspective StudiesBotulinum Toxins Type ADesmopressinRandomized Controlled Trials as TopicRetrospective StudiesUrinary bladderbusiness.industryUrinary Bladder OveractiveAntidiuretic AgentsPhosphodiesterase 5 Inhibitorsmedicine.diseasefemale genital diseases and pregnancy complicationsThiazolesmedicine.anatomical_structureOveractive bladderClinical Trials Phase III as Topic030220 oncology & carcinogenesisModels AnimalAcetanilidesFemaleNocturiamedicine.symptomMirabegronbusinessmedicine.drugEuropean urology focus
researchProduct